Top Story

Real World Data
Ibrutinib’s Success in CLL Treatment: Supported by Real World Data
April 26th, 2024
⁤Final results are in from the EVIdeNCE study, which analyzed 309 chronic lymphocytic leukemia (CLL) patients in Italy treated with ibrutinib (Imbruvica; AbbVie/Pharmacyclics), reaffirming the efficacy and safety previously shown in clinical trials. ⁤⁤Despite a significant number of patients with cardiovascular comorbidities, these conditions did not [...]
Read More

Latest Stories

Market Access
EU Probes China’s Medical Device Market Access
April 26th, 2024
Read More
Medical Affairs
Implications for Medical Affairs Teams in 2024 and Beyond
April 25th, 2024
Read More
Health Policy
Aerial Contagion: Redefining Airborne Pathogens
April 25th, 2024
Read More
Health Equity
Bridging Urban-Rural Healthcare Gaps Through Real-World Data
April 24th, 2024
Read More
Real World Evidence
Chiesi Focuses on Patient-Centered Care in Fabry Disease
April 24th, 2024
Read More
HEOR
ISPOR 2024: Keynote Speakers and Sessions Announced
April 23rd, 2024
Read More

HEOR

Ibrutinib’s Success in CLL Treatment: Supported by Real World Data

Jasmin Skinner2024-04-26T12:51:50-04:00April 26th, 2024|

EU Probes China’s Medical Device Market Access

Jasmin Skinner2024-04-26T12:37:46-04:00April 26th, 2024|

Implications for Medical Affairs Teams in 2024 and Beyond

Jasmin Skinner2024-04-24T22:30:17-04:00April 25th, 2024|

RWE

Chiesi Focuses on Patient-Centered Care in Fabry Disease

Paige McGarry2024-04-25T03:00:46-04:00April 24th, 2024|

Forecast of the Global Real World Evidence (RWE) Solutions Market

Jasmin Skinner2024-04-22T13:54:24-04:00April 22nd, 2024|

Study Reveals Racial Disparities in Prostate Cancer Care

Paige McGarry2024-04-16T21:21:17-04:00April 16th, 2024|

Market Access

EU Probes China’s Medical Device Market Access

Jasmin Skinner2024-04-26T12:37:46-04:00April 26th, 2024|

Expansion and Enhancement of Telehealth and Teletherapy Services Post-Pandemic

Paige McGarry2024-04-17T14:33:27-04:00April 17th, 2024|

HEOR & Market Access Global Salary Survey (2024)

Mary2024-04-01T13:28:15-04:00March 13th, 2024|

Featured Webinars

Practical AI: Adding Insight to the Patient Journey with Digital Phenotyping

Thursday, May 23, 2024

Sponsor: OM1

In this webinar, Dr. Joseph Zabinski will discuss the digital phenotyping process and several concrete applications to demonstrate how AI can [...]

Insights from the 2024 Salary Survey Report by HealthEconomics.com

Wednesday, May 1, 2024

Webinar Host: Scientist.com

The live session will focus on the latest salary and bonus trends for professionals in the field, including a comprehensive overview [...]

Beyond Accelerated Approvals: External Control Arms

Wednesday, April 10, 2024

Sponsor: Cardinal Health

Hear this panel's discussion on the strategic use of external control arms and, if done correctly, how they can help bring [...]

Delphi Panels: What Are They Good For?

Tuesday, March 12, 2024

Sponsor: Partnership for Health Analytic Research (PHAR)

In this webinar, experts deep dive into Delphi panel methods, their implementation, and pharmaceutical industry insights on the panels' use and [...]

Handpicked Promotions & Highlights

Latest in Catalyst News powered by BioPharmCatalyst

04/26/2024 04:44 PM ET

ImmunityBio ABIO earnings announcement

ARCA biopharma revealed their most recent quarterly earnings data for Q1. EPS was reported to be -$0.14.

The market liked what it heard. ARCA biopharma rocketed up $0.10 (+2.87%) to $3.58 on light volume [...]

04/26/2024 04:44 PM ET

ProKidney PTCT earnings announcement

PTC Therapeutics exceeded their revenue estimate and fell in line with their EPS estimate, according to their recent quarterly earnings data. Revenue was $210.12M, exceeding estimates by 23.8%.

Not surprisingly, the [...]

04/25/2024 04:46 PM ET

Processa Pharmaceuticals BCDA date announcement

BioCardia has an announcement scheduled for December 31, 2024 regarding their recent Phase 3 trial of CardiAMP (BCDA-02). The community is currently bullish on the prospects of progression, as the bulls outnumber bears by five [...]